Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera.

BioRxiv : the Preprint Server for Biology
Xuping XiePei-Yong Shi


Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and South Africa share the spike N501Y substitution, which is of particular concern because it is located in the viral receptor binding site for cell entry and increases binding to the receptor (angiotensin converting enzyme 2). We generated isogenic N501 and Y501 SARS-CoV-2. Sera of 20 participants in a previously reported trial of the mRNA-based COVID-19 vaccine BNT162b2 had equivalent neutralizing titers to the N501 and Y501 viruses.


Jan 23, 2021·Vaccines·Alberto Cagigi, Karin Loré
Jan 21, 2021·The Journal of Infection·Julian W TangDavid D S Hui
Jan 29, 2021·JAMA : the Journal of the American Medical Association·John P Moore, Paul A Offit
Feb 12, 2021·International Journal of Molecular Sciences·Bruno O VilloutreixAbdel-Majid Khatib
Jan 31, 2021·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Amanda FernandesGeetha Gopalakrishnan
Feb 11, 2021·Nature·Zijun WangMichel C Nussenzweig
Mar 7, 2021·Viruses·Kenneth Lundstrom
Apr 6, 2021·Frontiers in Immunology·Jaime Fergie, Amit Srivastava
Apr 15, 2021·Expert Review of Vaccines·Lianlian BianZhenglun Liang
Apr 11, 2021·Postgraduate Medical Journal·Gabor Zoltan XantusPeter Kanizsai
May 13, 2021·Nature Communications·Stefania DispinseriGabriella Scarlatti
Jun 3, 2021·Nature Reviews. Microbiology·William T HarveyDavid L Robertson
Jun 11, 2021·Signal Transduction and Targeted Therapy·Weilin Zhou, Wei Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.